Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 11.44 | 7.13 | 8.06 | 2.95 |
Total Revenue | 11.44 | 7.13 | 8.06 | 2.95 |
Costof Revenue Total | 6.98 | 4.10 | 4.96 | 1.82 |
Gross Profit | 4.46 | 3.03 | 3.10 | 1.13 |
Selling/ General/ Admin Expenses Total | 2.09 | 1.23 | 1.03 | 0.47 |
Depreciation/ Amortization | 0.10 | 0.10 | 0.07 | 0.00 |
Other Operating Expenses Total | 0.96 | 0.85 | 0.69 | 0.20 |
Total Operating Expense | 10.13 | 6.28 | 6.75 | 2.49 |
Operating Income | 1.31 | 0.85 | 1.31 | 0.46 |
Interest Inc( Exp) Net- Non- Op Total | -0.35 | -0.92 | -0.58 | 0.00 |
Other Net | 0.30 | 0.06 | -0.08 | 0.00 |
Net Income Before Taxes | 1.57 | 0.81 | 1.17 | 0.46 |
Provisionfor Income Taxes | 0.42 | 0.24 | 0.36 | 0.11 |
Net Income After Taxes | 1.15 | 0.58 | 0.81 | 0.36 |
Net Income Before Extra Items | 1.15 | 0.58 | 0.81 | 0.36 |
Net Income | 1.15 | 0.58 | 0.81 | 0.36 |
Total Adjustmentsto Net Income | 0.00 | - | - | - |
Income Availableto Com Excl Extra Ord | 1.15 | 0.58 | 0.81 | 0.36 |
Income Availableto Com Incl Extra Ord | 1.15 | 0.58 | 0.81 | 0.36 |
Diluted Net Income | 1.15 | 0.58 | 0.81 | 0.36 |
Diluted Weighted Average Shares | 0.17 | 0.17 | 0.17 | 0.17 |
Diluted EPS Excluding Extra Ord Items | 6.84 | 3.43 | 4.81 | 2.13 |
Diluted Normalized EPS | 6.84 | 3.43 | 4.81 | 2.13 |
DPS- Common Stock Primary Issue | - | - | 0.00 | 0.00 |
EP Biocomposites Dividend EP Biocomposites Bonus EP Biocomposites News EP Biocomposites AGM EP Biocomposites Rights EP Biocomposites Splits EP Biocomposites Board Meetings EP Biocomposites Key Metrics EP Biocomposites Shareholdings EP Biocomposites Balance Sheet EP Biocomposites Cashflow EP Biocomposites Q1 Results EP Biocomposites Q2 Results EP Biocomposites Q3 Results EP Biocomposites Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks